BioTheryX Stock

biotheryx.comBioTechFounded: 2007Funding to Date: $173.09MM

BioTheryX restores protein homeostasis through protein modulation, including protein degradation as well as multi-kinase inhibition, to develop treatments that extend and improve the quality-of-life of patients with life-threatening diseases.

Register for Details

For more details on financing and valuation for BioTheryX, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for BioTheryX.

Register Today

Other companies like BioTheryX in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$3.1B
Sector
 
 
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$1.77B